IMMU (IMMU) News
Follow IMMU (IMMU) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Mendus Extends Maturity Date Of Loan Facility To 30 April 2027
Mendus AB (publ) OMXSTO:IMMU
NEWS | Sep 14, 2026, 06:03 AM UTC
L
Mendus draws under the second tranche of the Fenja Capital II A/S loan facility, extending cash runway into the second quarter of 2027
Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies for myeloid blood cancers, today announces that the Company will draw down SEK 16.5 million under a second tranche of the loan f
NEWS | Sep 14, 2026, 06:00 AM UTC